Biontech Se Stock Price To Earning
| 0A3M Stock | USD 112.90 2.16 1.95% |
BioNTech SE fundamentals help investors to digest information that contributes to BioNTech's financial success or failures. It also enables traders to predict the movement of BioNTech Stock. The fundamental analysis module provides a way to measure BioNTech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioNTech stock.
BioNTech | Price To Earning |
BioNTech SE Company Price To Earning Analysis
BioNTech's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
BioNTech Retained Earnings
Retained Earnings |
|
Based on the latest financial disclosure, BioNTech SE has a Price To Earning of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to earning for all United Kingdom stocks is 100.0% higher than that of the company.
Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
| All Next | Launch Module |
BioNTech Fundamentals
| Return On Equity | 0.24 | ||||
| Return On Asset | 0.17 | ||||
| Profit Margin | 0.48 % | ||||
| Operating Margin | 0.64 % | ||||
| Current Valuation | 10.83 B | ||||
| Shares Outstanding | 239.77 M | ||||
| Shares Owned By Insiders | 65.11 % | ||||
| Shares Owned By Institutions | 17.59 % | ||||
| Price To Book | 1.40 X | ||||
| Price To Sales | 3.49 X | ||||
| Revenue | 3.82 B | ||||
| Gross Profit | 16.07 B | ||||
| EBITDA | 5.94 B | ||||
| Net Income | 930.3 M | ||||
| Cash And Equivalents | 914.9 M | ||||
| Cash Per Share | 3.75 X | ||||
| Total Debt | 28.1 M | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 2.67 X | ||||
| Book Value Per Share | 83.02 X | ||||
| Cash Flow From Operations | 5.37 B | ||||
| Earnings Per Share | 18.00 X | ||||
| Price To Earnings To Growth | 0.05 X | ||||
| Target Price | 219.54 | ||||
| Number Of Employees | 5.5 K | ||||
| Beta | 0.24 | ||||
| Market Capitalization | 32.02 B | ||||
| Total Asset | 23.01 B | ||||
| Retained Earnings | 19.76 B | ||||
| Working Capital | 17.46 B | ||||
| Net Asset | 23.01 B |
About BioNTech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BioNTech SE's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioNTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioNTech SE based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioNTech SE. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .